Part 1 placebo

DRUG2 trials

Sponsors

Klotho Sciences Australia Pty Ltd., Drugs for Neglected Diseases Initiative

Conditions

Alzheimer DiseaseChronic Kidney DiseaseHealthy ParticipantsOnchocerciasis

Phase 1

A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers

Not yet recruitingNCT07143331

Klotho Sciences Australia Pty Ltd.Alzheimer Disease, Chronic Kidney Disease, Healthy Participants

Start: 2025-08-30End: 2026-08-06Target: 84Updated: 2025-08-27

Phase 2

Emodepside phase II trial for treatment of onchocerciasis

Active, not recruitingPACTR202010898529928

Drugs for Neglected Diseases InitiativeOnchocerciasis

Start: 2021-03-19Target: 578Updated: 2026-09-14